For instance, chemotherapy has been shown to upregulate PD-L1 expression, with some studies reporting a 35% increase in PD-L1 levels in patients with recurrent NSCLC after platinum-based chemotherapy [17]. Here, CD274 is linked to non-small cell lung carcinoma.